25-hydroxyvitamin D (25-hydroxyvitamin D ) - India CDSCO Medical Device Registration

25-hydroxyvitamin D (25-hydroxyvitamin D ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000207_af0258917b8b1048e03532352f021283_e495c620baa4e97451619cc5439945f0. This device is marketed under the brand name CLIA. The license holder is Rapid House, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

25-hydroxyvitamin D (25-hydroxyvitamin D )

UID: IMP/IVD/2023/000207_af0258917b8b1048e03532352f021283_e495c620baa4e97451619cc5439945f0

Brand Name

CLIA

License Holder

Rapid House

Device Class

Class B

Approving Authority

CDSCO

Product Information

It is used for hydroxyvitamin D Assay (CLIA) is used for the quantitative in vitro detection of 25 hydroxyvitamin D in human serum plasma and whole Blood